On an extension of a mathematical model for tumor anti-angiogenesis
From MaRDI portal
Publication:425828
DOI10.1016/j.na.2009.05.037zbMath1239.93073OpenAlexW2074869088MaRDI QIDQ425828
Heinz Schättler, Urszula Łedzewicz-Kowalewska
Publication date: 9 June 2012
Published in: Nonlinear Analysis. Theory, Methods \& Applications. Series A: Theory and Methods (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.na.2009.05.037
Application models in control theory (93C95) PDEs in connection with biology, chemistry and other natural sciences (35Q92)
Related Items
Stability of Hahnfeldt angiogenesis models with time lags, Effect of treatment on the global dynamics of delayed pathological angiogenesis models
Cites Work
- Optimal scheduling of radiotherapy and angiogenic inhibitors
- Using mathematical modeling as a resource in clinical trials
- Critical-point analysis for three-variable cancer angiogenesis models
- Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models
- The response to antiangiogenic anticancer drugs that inhibit endothelial cell proliferation
- Continuous and discrete mathematical models of tumor-induced angiogenesis
- Hopf point analysis for angiogenesis models
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis
- Singular trajectories and their role in control theory
- Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)
- AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
- Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment
